Benjamin John Wagner, PA

Benjamin Wagner practices at Dent Neurologic Institute in Amherst, New York.

Benjamin Wagner's NPI, 1447591565, was assigned on March 14, 2013. Benjamin Wagner holds New York license 016475.

Benjamin Wagner's primary practice is Dent Neurologic Institute, at 3980 Sheridan Dr, Amherst, NY 14226-1727. The practice phone is (716) 250-2000.

Benjamin Wagner's primary practice is Dent Neurologic Institute in Amherst, New York. Benjamin Wagner is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is DENT Neurologic Institute. Dmand AI also links Benjamin Wagner to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Benjamin Wagner practices, 4 sites in all. Vendor and product names are available with a free account.

Medical is Benjamin Wagner's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Benjamin Wagner is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Benjamin Wagner is licensed in New York.

Dmand AI lists ADHD, adjustment disease, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia and intellectual and developmental disabilities among the conditions Benjamin Wagner treats.

CMS data shows 1,158 Medicare services from Benjamin Wagner across 7 procedure codes in 2024, for 162 Medicare patients. Medicare paid $41,308 for them. Every service was in an office.

CMS counts 162 Medicare patients who saw Benjamin Wagner in 2024. The largest group is under 65, with 111 patients. 75% of them have high cholesterol, and 70% have anxiety. 82% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Benjamin Wagner's median patient age at 49, with 57% women.

In 2024, Benjamin Wagner wrote 7,896 Medicare Part D claims for 391 patients. 91% of them were for generic drugs. CMS names the drug for 7,698 of them, across 80 drugs with 11 or more claims each, at $1,281,793 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 44 out of 100 for Benjamin Wagner for performance year 2024, reported as part of a group. Benjamin Wagner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Benjamin Wagner as offering telehealth.

CMS Open Payments shows 225 general payments to Benjamin Wagner from 22 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Neurocrine BioSciences, Inc. paid the most, $574.

Benjamin Wagner is a member of AAPA.